Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with pure apical hypertrophic cardiomyopathy

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Kim, Kyung Hee ^a   Kim, Hyung Kwan ^a   Hwang, In Chang ^a   Lee, Seung Pyo ^a   Park, Eun Ah ^a   Lee, Whal ^a   Kim, Yong Jin ^a   Park, Jae Hyung ^a   Sohn, Dae Won ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Apical hypertrophic cardiomyopathy; Cardiovascular magnetic resonance; Late gadolinium enhancement

Indexed keywords

GADOLINIUM;

ADULT; APICAL HYPERTROPHIC CARDIOMYOPATHY; ARTICLE; BLOOD VESSEL WALL; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DEATH; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE INJURY; HOSPITALIZATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; LATE GADOLINIUM ENHANCEMENT; MALE; MYOCARDIAL SCARRING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SUDDEN DEATH; T WAVE INVERSION;

CARDIOMYOPATHY, HYPERTROPHIC; CICATRIX; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84864191784     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-52     Document Type: Article

References (28)

1. Long-term outcome in patients with apical hypertrophic cardiomyopathy. Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, Rakowski H, J Am Coll Cardiol. 2002 39 638 45 10.1016/S0735-1097(01)01778-8 11849863 (Pubitemid 34158160)
2. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Moon JC, Fisher NG, McKenna WJ, Pennell DJ, Heart. 2004 90 645 9 10.1136/hrt.2003.014969 15145868 (Pubitemid 38668538)
3. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, Petrou M, Pennell DJ, J Am Coll Cardiol. 2004 43 2260 2264 10.1016/j.jacc.2004.03.035 15193690 (Pubitemid 38757595)
4. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ, J Am Coll Cardiol. 2002 40 2156 64 10.1016/S0735-1097(02)02602-5 12505229 (Pubitemid 36005903)
5. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances. Amano Y, Takayama M, Takahama K, Kumazaki T, J Magn Reson Imaging. 2004 20 595 600 10.1002/jmri.20172 15390225 (Pubitemid 39313735)
6. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. Kwon DH, Smedira NG, Rodriguez ER, Tan C, Setser R, Thamilarasan M, Lytle BW, Lever HM, Desai MY, J Am Coll Cardiol. 2009 54 242 9 10.1016/j.jacc.2009.04.026 19589437
7. Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: a comparative study. Yamada M, Teraoka K, Kawade M, Hirano M, Yamashina A, Int J Cardiovasc Imaging. 2009 25 Suppl 1 131 8 19165622
8. Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy. Fattori R, Biagini E, Lorenzini M, Buttazzi K, Lovato L, Rapezzi C, Am J Cardiol. 2010 105 1592 6 10.1016/j.amjcard.2010.01.020 20494668
9. Phenotypic spectrum and clinical characteristics of apical hypertrophic cardiomyopathy: multicenter echo-Doppler study. Choi EY, Rim SJ, Ha JW, Kim YJ, Lee SC, Kang DH, Park SW, Song JK, Sohn DW, Chung N, Cardiology. 2008 110 53 61 10.1159/000109407 17934270 (Pubitemid 351489168)
10. Left ventricular twist mechanics in patients with apical hypertrophic cardiomyopathy: assessment with 2D speckle tracking echocardiography. Chang SA, Kim HK, Kim DH, Kim JC, Kim YJ, Kim HC, Sohn DW, Oh BH, Park YB, Heart. 2010 96 49 55 10.1136/hrt.2009.166629 19858137
11. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, Circulation. 2002 105 539 42 10.1161/hc0402.102975 11815441 (Pubitemid 34262671)
12. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, J Am Coll Cardiol. 2008 51 1369 1374 10.1016/j.jacc.2007.11.071 18387438 (Pubitemid 351443083)
13. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL, Meininger GR, Roguin A, Calkins H, Tomaselli GF, Weiss RG, Berger RD, Lima JA, Halperin HR, Circulation. 2005 112 2821 2825 10.1161/CIRCULATIONAHA.105.549659 16267255 (Pubitemid 41641676)
14. Giant t wave inversion as a manifestation of asymmetrical apical hypertrophy (aah) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study. Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada Y, Japanese Heart Journal. 1976 17 611 10.1536/ihj.17.611 136532
15. Hypertrophic nonobstructive cardiomyopathy with giant negative t waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients. Yamaguchi H, Ishimura T, Nishiyama S, Nagasaki F, Nakanishi S, Takatsu F, Nishijo T, Umeda T, Machii K, Am J Cardiol. 1979 44 401 12 10.1016/0002-9149(79)90388-6 573056 (Pubitemid 10233856)
16. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Kitaoka H, Doi Y, Casey SA, Hitomi N, Furuno T, Maron BJ, Am J Cardiol. 2003 92 1183 6 10.1016/j.amjcard.2003.07.027 14609593 (Pubitemid 37377828)
17. Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy). Maron BJ, Bonow RO, Seshagiri TN, Roberts WC, Epstein SE, Am J Cardiol. 1982 49 1838 48 10.1016/0002-9149(82)90200-4 6211078 (Pubitemid 12059037)
18. New subtype of apical hypertrophic cardiomyopathy identified with nuclear magnetic resonance imaging as an underlying cause of markedly inverted T waves. Suzuki J, Watanabe F, Takenaka K, Amano K, Amano W, Igarashi T, Aoki T, Serizawa T, Sakamoto T, Sugimoto T, et al. J Am Coll Cardiol. 1993 22 1175 81 10.1016/0735-1097(93)90434-3 8409057 (Pubitemid 23285773)
19. Hypertrophic cardiomyopathy: a systematic review. Maron BJ, JAMA. 2002 287 1308 20 10.1001/jama.287.10.1308 11886323 (Pubitemid 34250486)
20. Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED, J Am Coll Cardiol. 2003 42 1687 713 10.1016/S0735-1097(03)00941-0 14607462 (Pubitemid 37383745)
21. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, Weil J, Zenovich AG, Maron BJ, Circulation. 2005 112 855 61 10.1161/CIRCULATIONAHA.104.507723 16087809 (Pubitemid 41170072)
22. Recognition of regional hypertrophy in hypertrophic cardiomyopathy using thallium-201 emission-computed tomography: comparison with two-dimensional echocardiography. Suzuki Y, Kadota K, Nohara R, Tamaki S, Kambara H, Yoshida A, Murakami T, Osakada G, Kawai C, Tamaki N, et al. Am J Cardiol. 1984 53 1095 102 10.1016/0002-9149(84)90644-1 6230927 (Pubitemid 14174259)
23. Detection of apical hypertrophic cardiomyopathy by magnetic resonance imaging. Casolo GC, Trotta F, Rostagno C, Poggesi L, Galanti G, Masotti G, Bartolozzi C, Dabizzi RP, Am Heart J. 1989 117 468 72 10.1016/0002-8703(89) 90793-X 2916416 (Pubitemid 19059797)
24. Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging. Pons-Lladá G, Carreras F, Borrás X, Palmer J, Llauger J, Bayés de Luna A, Am J Cardiol 1997 79 1651 6 10.1016/S0002-9149(97)00216-6 9202357 (Pubitemid 27339476)
25. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ, Eur Heart J. 2005 26 1461 74 10.1093/eurheartj/ehi258 15831557 (Pubitemid 41373486)
26. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. Matsubara K, Nakamura T, Kuribayashi T, Azuma A, Nakagawa M, J Am Coll Cardiol. 2003 42 288 95 10.1016/S0735-1097(03)00576-X 12875766 (Pubitemid 36851420)
27. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ, Lancet. 2001 357 21 8 10.1016/S0140-6736(00)03567-4 11197356 (Pubitemid 32056497)
28. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM, Circulation 1999 100 1992 2002 10.1161/01.CIR.100.19.1992 10556226 (Pubitemid 29529292)